Return to home page
Searching: Muskingum library catalog
We are currently experiencing delivery delays for items requested from other institutions while transitioning to a new statewide delivery service. Please contact your library with questions or advice about alternative resources. Thank you for your patience!
  Previous Record Previous Item Next Item Next Record
 
COMPUTER FILE
Title Guidance for industry : Q3B(R2) impurities in new drug products.
Imprint Rockville, MD : U.S. Dept. of Health and Human Services, Food and Drug Administration, Center for Biologics Evaluation and Research, [2006]

LOCATION CALL # STATUS MESSAGE
 ONLINE GOVERNMENT PUBLICATION  HE 20.4702:IM 7/2    ONLINE  
LOCATION CALL # STATUS MESSAGE
 ONLINE GOVERNMENT PUBLICATION  HE 20.4702:IM 7/2    ONLINE  
Subject Drug development -- Government policy -- United States.
Drug adulteration -- Government policy -- United States.
Alt Name Center for Drug Evaluation and Research (U.S.)
Center for Biologics Evaluation and Research (U.S.)
International Conference on Harmonisation.
Add Title Q3B(R2) impurities in new drug products
Impurities in new drug products
Description 8 pages : digital, PDF file
Note Title from PDF title page (viewed on June 15, 2009).
"ICH".
"July 2006".
"Revision 2".
System Details Mode of access: Internet at the FDA web site. Address as of 6/15/09: http://www.fda.gov/downloads/RegulatoryInformation/Guidances/ucm128033.pdf ; current access is available via PURL.
OCLC # 399838071



If you experience difficulty accessing or navigating this content, please contact the OPAL Support Team